• Profile
Close

Assessing C reactive protein/albumin ratio as a new biomarker for polycystic ovary syndrome: A case–control study of women from Bahraini medical clinics

BMJ Open Nov 01, 2018

Kalyan S, et al. - In this case-control study, researchers assessed serum C reactive protein (CRP)/albumin ratio as a potential predictive biomarker for polycystic ovary syndrome (PCOS), as well as compared the association between CRP/albumin and PCOS to variables classically related to the syndrome. Study participants were 200 premenopausal women with a diagnosis of PCOS, and 119 ethnically matched eumenorrheic premenopausal women. The study results showed that CRP/albumin ratio was a stronger correlate of PCOS than both free androgens and insulin resistance. They found that inflammation is known to be influenced by adiposity, but relative to controls, women with PCOS have higher levels of CRP/albumin regardless of body mass index (BMI). Therefore, supporting the view that inflammation plays a central role in the pathophysiology of PCOS.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay